Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 5, 2017Virtual Press Office and PR Newswire: General Trade show news
Nektar Therapeutics (Nasdaq: NKTR) today announced that it presented new findings from two Phase 1 clinical studies of NKTR-214, Nektar's lead immuno-oncology candidate, a CD122-biased agonist, at...
-
Jun 5, 2017Virtual Press Office and PR Newswire: General Trade show news
Angionetics Inc., a majority-owned subsidiary of Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM), focused on the Phase 3 clinical development of Generx [Ad5FGF-4] cardiovascular...
-
Jun 5, 2017Virtual Press Office and PR Newswire: General Trade show news
Biotheranostics, Inc. today announced new data further demonstrating the importance of BCI in clinical practice. In a study of more than 14,000 cases, the largest patient study for BCI, BCI...
-
Jun 5, 2017Virtual Press Office and PR Newswire: General Trade show news
"Haitao", the term "cross border online shopping" in Chinese, it is becoming more and more popular to shop at overseas online platforms for Chinese consumers, as the increasing disposable income...
-
Jun 5, 2017Virtual Press Office and PR Newswire: General Trade show news
CSSi, the global leader in patient recruitment, enrollment, and retention solutions for the clinical research industry, will be exhibiting in booth #1951 at the upcoming 53rd Drug Information...